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Many animal species use a chromosome-based mechanism of sex determination, which has led to
the coordinate evolution of dosage-compensation systems. Dosage compensation not only corrects
the imbalance in the number of X chromosomes between the sexes but also is hypothesized to
correct dosage imbalance within cells that is due to monoallelic X-linked expression and biallelic
autosomal expression, by upregulating X-linked genes twofold (termed ‘Ohno’s hypothesis’).
Although this hypothesis is well supported by expression analyses of individual X-linked genes
and by microarray-based transcriptome analyses, it was challenged by a recent study using RNA
sequencing and proteomics. We obtained new, independent RNA-seq data, measured RNA
polymerase distribution and reanalyzed published expression data in mammals, C. elegans and
Drosophila. Our analyses, which take into account the skewed gene content of the X chromosome,
support the hypothesis of upregulation of expressed X-linked genes to balance expression of the
genome.
The evolution of a specific set of sex-determining chromosomes has led, in many species, to
the existence of a single X chromosome in males and two in females. Unchecked, this
mechanism of sex determination would result both in unequal X-linked gene expression
between the sexes and in a naturally occurring ‘X aneuploidy’ in males. Chromosomal
aneuploidy, caused by loss or gain of large regions of the genome, results in disturbances in
the overall balance of gene expression networks, leading to reduced fitness and mortality1,2.
Thus, mechanisms to maintain balanced expression of the genome are vital3. To compensate
for haploinsufficiency of X-linked genes in males and to restore equal expression between
the sexes, dosage-compensation mechanisms evolved, which differ between organisms. In
D. melanogaster, expression of most X-linked genes is increased about twofold selectively
in males to achieve balanced expression with the autosomes and to equalize expression with
females4,5. In mammals and C. elegans, two processes have evolved: (i) a mechanism to
equalize X-linked gene expression between the sexes by either silencing one X chromosome
in mammalian females (X inactivation)6 or repressing both X chromosomes in C. elegans
hermaphrodites7 and (ii) a mechanism hypothesized to upregulate expression from the X
chromosome in both sexes8,9. Whereas the doubling of X-linked gene expression in
Drosophila has been well documented, evidence for X-linked gene upregulation in mammals
and C. elegans is relatively recent. Measurements of Clcn4-2 expression in different species
of mice and analyses of expression microarray data provided the first evidence for the
upregulation of genes on the X chromosome8–10. In XX or XY cells, the ratio of X-linked to
autosomal expression as measured by microarrays was ~1. This held true in several tissues
from multiple mammalian species, as well as in C. elegans and Drosophila8,9.
A recent study concluded that, in contrast to expression array data, RNA sequencing data do
not support dosage compensation of the active X chromosome in mammals and adult C.
elegans, thereby rejecting Ohno’s hypothesis11. Based on reanalyses of published RNA-seq
data, the authors calculated that X:autosome (X:A) median expression ratios were ~0.5 in
humans and 0.3 in mice, whereas in C. elegans, ratios declined from 1.0 in embryos to 0.4 in
adults. However, as shown here, these ratios are strongly influenced by the preponderance of
reproduction-related genes on the X chromosome that are silent in somatic tissues12 and by
special aspects of X chromosome regulation in germ cells13–15. Our reanalyses of published
RNA-seq data and data from new experiments, which take into consideration the skewed
gene content and regulation of the X chromosome, uphold the idea that there is
compensation of gene expression between the X chromosome and autosomes in both sexes
of mammals, C. elegans and Drosophila.
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RNA-seq data confirm X upregulation in mammals
To determine whether X-linked genes were expressed at twice the level of autosomal genes
per active allele in mammals, we first investigated whether the X chromosome and
autosomes had similar expression profiles. We suspected that the skewed gene content of the
mammalian X chromosome would affect the distribution of gene expression because
reproduction-related genes have low or no expression in somatic tissues16–18. The
distribution of X-linked and autosomal gene expression was determined in multiple human
and mouse tissues and cell lines by the reanalysis of a subset of the same RNA-seq data sets
analyzed previously11, in addition to the evaluation of newly released RNA-seq data sets
(Supplementary Table 1). In all human and mouse samples examined, the frequency of
genes with no expression (0 fragments per kilobase of exon per million mapped fragments
(FPKM)) was significantly higher on the X chromosome than on autosomes (P < 0.05, by
Fisher’s exact test; Supplementary Fig. 1a and Supplementary Table 2). As demonstrated in
the following section, many of these are multicopy genes expressed in the testis.
The distributions of gene expression were similar between the X chromosome and
autosomes in brain and five other human tissues (P > 0.05, by Kolmogorov-Smirnov test),
even when including all genes with any evidence of expression (>0 FPKM) (Fig. 1a,
Supplementary Fig. 1b and Supplementary Table 2). This finding was also demonstrated by
a computational doubling of X-linked expression values, which produced a theoretical curve
shifted far to the right of autosomal expression values, rather than the overlapping curves
that would be anticipated if expression on the X chromosome was not upregulated (Fig. 1a).
A cutoff of >0 FPKM includes some genes that are actually silent but that record reads as a
result of biological noise or noise from the process of sequencing and read-mapping19. For
genes with more robust expression (≥1 FPKM), the distributions of X-linked and autosomal
expression became statistically indistinguishable in 12 of 16 human tissues, consistent with
the upregulation of expressed X-linked genes (P > 0.05, by Kolmogorov-Smirnov test;
Supplementary Table 2). Additional RNA-seq data from four human ENCODE cell lines
confirmed results obtained in human tissues (Supplementary Fig. 2a and Supplementary
Table 2). Computational doubling of X-linked expression values also shifted the X-
chromosome curve to the right of the autosomal curve. We then compared gene expression
from individual chromosomes. Box plots showed no significant differences between the X
chromosome and each human autosome (P > 0.05, one-way ANOVA test for genes with >0
FPKM; Fig. 1b). In addition, the average distribution of X-linked expression in 41 human
lymphoblastoid cell lines20 was not significantly different from autosomal expression (P >
0.05 for 15 of 22 autosomes, by Kolmogorov-Smirnov test for genes with >0 FPKM; Fig.
1c).
The calculated X:A median expression ratios based on RNA-seq data were strongly
dependent on inclusion or removal of genes with no or low expression (Fig. 1d and
Supplementary Table 2). Comparisons between 41 male and female lymphoblastoid cell
lines20 also revealed variability between individual samples, albeit no apparent significant
sex differences (P > 0.05, by Student’s t-test; Fig. 1d and Supplementary Fig. 2b). Given the
skewed X:A distribution of genes with spatially or temporally restricted expression, for
example reproduction-related genes, it is clear that X:A median expression ratios are
distorted and that a better approach is to compare complete distributions of X-linked and
autosomal gene expression, as shown above (Fig. 1). The advantage of using distributions
was also seen by calculating X:A median expression ratios for genes separated into 16 bins,
each containing the same number of X-linked genes (33–59, dependent on tissue) and
autosomal genes (933–1,396) (Fig. 1e and Supplementary Fig. 2b). Note that brain has the
highest X:A median expression ratio, as previously reported9. For all tissues, the X:A
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median expression ratios were variable for bins containing genes with low expression and
gradually increased from ~0.7 to ~1.0 for bins containing genes with expression
measurements ≥1 FPKM. Thus, the inclusion of non-expressed or very weakly expressed
genes that result from the skewed gene content of the X chromosome masks the
upregulation of X-linked genes.
Likewise, in mouse tissues, the distributions of X-linked and autosomal expression were
similar for genes with ≥0 FPKM in brain and for genes with ≥1 FPKM in other tissues (P >
0.05, by Kolmogorov-Smirnov test; Fig. 2a, Supplementary Fig. 3 and Supplementary Table
2). There was no significant difference between the X chromosome and 14 of 19 mouse
autosomes (P > 0.05, one-way ANOVA test for genes with >0 FPKM; Fig. 2b). In mouse as
well, the calculated X:A median expression ratios based on RNA-seq data were strongly
dependent on the inclusion or removal of genes that were expressed weakly or not expressed
(Fig. 2c). The combined analyses of human and mouse tissues and cell lines not only reveal
a high frequency of X-linked genes with no or low expression but also support the idea that
most expressed genes on the single active X chromosome are upregulated to achieve a
similar level of expression to that of autosomes present in two copies.
The mammalian X chromosome is enriched in tissue-specific genes
Tissue-specific genes implicated in sexual reproduction have accumulated on the
mammalian X chromosome. The nonrandom distribution of genes with gonad and brain
expression would have a profound effect on the evaluation of Ohno’s hypothesis.
Reproduction-related genes on the human X chromosome include 13 multicopy families of
cancer-testis antigen genes and represent at least 10% of the X-linked genes17,21,22. Genes
expressed in brain are also abundant on the human X chromosome23–25. On the mouse X
chromosome, about 18% of genes are included in 33 multicopy gene families representing a
total of 273 genes that are mainly expressed in postmeiotic male germ cells18. Genes
expressed in premeiotic male germ cells and somatic cells of the testis, as well as in female-
specific tissues such as placenta and the ovary, also predominate on the mouse X
chromosome16,26. Thus, it was not unexpected that the two tissues that had the lowest
percentage of non-expressed X-linked genes were testis (16%) and brain (22%), as
compared to other tissues (23–40%) (P < 4 × 10−7, by Fisher’s exact test between testis and
other tissues; Supplementary Fig. 1a and Supplementary Table 2).
In human testis, the distributions of gene expression remained significantly different
between the X chromosome and autosomes, even for well-expressed genes with >2 FPKM
(P = 1 × 10−4, by Kolmogorov-Smirnov test; Supplementary Table 2). This finding
suggested that a specific set of genes is expressed in the testis. We conducted pairwise
analyses to compare the testis to other human tissues by plotting the distribution of testis
expression for the subsets of X-linked and autosomal genes that were not expressed (0
FPKM) in a given somatic tissue (liver, adrenal gland and lung). A higher proportion of
these genes were X linked rather than autosomal, confirming the preponderance of
reproduction-related genes on the X chromosome (P < 1 × 10−7, by Kolmogorov-Smirnov
test; Fig. 1f and Supplementary Fig. 4). For example, of 3,066 genes with 0 FPKM in human
liver and >0 FPKM in human testis, 192 were X linked (22% of the total number of X-
linked genes assayed) and 2,874 were autosomal (14% of the total number of autosomal
genes assayed) (P = 4 × 10−9, by Fisher’s exact test; Supplementary Table 3). Comparisons
between somatic tissues did not show this trend (Supplementary Fig. 4). Six of the top ten
functional categories (false discovery rate (FDR) score 2 × 10−8) obtained by Gene
Ontology analyses of the subset of X-linked genes with no or very low expression (0–0.1
FPKM) in human somatic tissues were reproduction-related. Similarly, more than 93% of
known reproduction-related genes16,18 were not expressed in mouse somatic tissues
(Supplementary Table 4). We conclude that reproduction-related genes contribute to X-
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linked genes that are not expressed or are expressed at low levels in somatic tissues of
mammals. When we correct for this biased distribution, RNA-seq data are strongly
consistent with the predictions of Ohno’s hypothesis of similar expression levels between
the X chromosome and autosomes.
RNA PolII-S5p occupancy is higher on X-linked genes
If upregulation of the X chromosome occurs at the level of transcription, one would expect
higher occupancy by active forms of RNA polymerase II on the X chromosome. To test this
idea, we used an undifferentiated female embryonic stem (ES) cell line (PGK12.1) with two
active X chromosomes and an X:A expression ratio of 1.4 (ref. 27). Because the X:A
expression ratio should theoretically be 2 if X-linked expression were doubled by dosage-
compensation mechanisms, the observed lower ratio suggests that dampening of X-linked
expression occurs in PGK12.1 cells, thus allowing the survival of this particular cell line28.
Most female ES cell lines lose one X chromosome, likely as a result of the deleterious
effects of high X-linked expression, which is also the probable cause of lethality in mouse
embryos engineered to retain two active X chromosomes29.
Chromatin immunoprecipitation combined with DNA array (ChIP-chip) analyses of
PGK12.1 cells showed, in two separate experiments, that the form of RNA polymerase II
that is phosphorylated at Ser5 (PolII-S5p), which is specifically associated with active
transcriptional initiation30, was more highly enriched at the 5′ end of genes on the X
chromosome than for autosomal genes (Fig. 3a and Supplementary Fig. 5). RNA-seq
analyses confirmed higher levels of expressed X-linked genes in this cell line (Fig. 3b).
When we sorted genes into nine bins based on expression, X-linked genes in the upper four
bins had higher PolII-S5p occupancy relative to autosomal genes (Fig. 3b). As expected, no
such difference between the X chromosome and autosomes was apparent among genes with
low or no expression. Scatter plots confirmed that PolII-S5p occupancy depended on
expression levels (Fig. 3c) as was shown in another system31. This RNA-independent
evidence strongly supports upregulation of expressed X-linked genes and provides a
plausible mechanism for mediating increased expression in mammals.
RNA-seq data in C. elegans somatic cells confirm X upregulation in both sexes
In C. elegans, Xiong et al. observed X:A median expression ratios of 0.92, 0.84, 0.69 and
0.41 for hermaphrodites at the L2, L3, L4 and adult stages, respectively11. These declining
ratios were interpreted to indicate that the C. elegans X chromosomes do not undergo
compensatory upregulation in later developmental stages11. However, the progressive
reduction in X:A expression ratio values during development is caused by a change in the
ratio of somatic to germ cells in the organism.
The anatomy of C. elegans has been fully described, and the precise lineage of each somatic
cell, which does not vary from animal to animal, is known32–35. When the embryo hatches,
there are 558 somatic cells, a subset of which undergo further division to yield
approximately 700 cells by the third larval stage (L3), and a total of exactly 959 somatic
cells are present in a mature hermaphrodite. Germline development commences after the
animal hatches, most rapidly during the late L3 and L4 stages. There are approximately 10
germ cells by the end of L2, 100 by the end of L3, 1,000 by the end of L4 and 2,000 in a
mature XX hermaphrodite adult36. Thus, the ratio of germ cells to somatic cells increases as
the animal develops. This is relevant because both X chromosomes are transcriptionally
silenced in germ cells13. Therefore, if the true X:A expression ratio in somatic cells were 1
(consistent with upregulation of X-linked genes to balance gene expression), we would
expect measured X:A expression ratios to be approximately 0.98 in L2, 0.87 in L3, 0.48 in
L4 and 0.32 in adults. These ratios are rough estimations, yet they very closely approximate
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the reported ratios (0.92, 0.84, 0.69 and 0.41)11. These data are therefore consistent with
known C. elegans biology and have no bearing on Ohno’s hypothesis.
To compare expression between the X chromosome and autosomes in somatic cells, where
genes on the X chromosome are known to be expressed, we performed RNA-seq on glp-1
(q224) XX L4 animals, which do not undergo germline proliferation. Consistent with the
previous analysis11, the X:A expression ratio was 0.51 in wild-type L4 animals with a
developing germline but was 0.99 in XX L4 animals lacking a germline (Table 1 and Fig. 4).
This result indicates that the lower X:A expression ratio in wild-type XX animals was
indeed due to the presence of the silenced X chromosomes in the germline.
Having established equalized levels of X-linked and autosomal expression in XX somatic
cells throughout development (Fig. 4), we next tested whether an animal with a single X
chromosome also showed equal X-linked and autosomal expression. First, we note that a
wild-type XO L4 male (also subject to the germline proliferation issue described above) has
an X:A expression ratio of 0.51, identical to that of an XX L4 hermaphrodite (Fig. 4 and
Table 1). Second, using microarrays, we found that the mean and median X:A expression
ratio in L3 animals that are karyotypically male was 0.98 (see Online Methods), indicating
that X-linked genes are upregulated in XO animals.
Proteomics data do not contradict Ohno’s hypothesis
We also re-examined published mouse proteomics data11,37, again taking X-chromosome
gene content into account in our analysis. We found a lower proportion of proteins encoded
by X-linked genes represented in the data set (10.8%) compared to autosomal genes
(17.5%). This is fully consistent with observations that a large proportion of X-linked genes
are not expressed in somatic tissues. If only the top 10.8% of proteins from autosomal genes
are used in calculating the X:A protein ratio, whereas all proteins from X-linked genes are
included (also 10.8%, but including very low-abundance proteins), we also obtain a low X:A
median protein ratio of 0.38 (ref. 11). However, if we use a threshold based on protein
abundance for calculating the X:A protein ratio, in this case only considering autosomal and
X-linked genes for which the corresponding proteins are found at least once in the data set,
the X:A median protein ratio is 1.07 (P = 0.73, Mann-Whitney test). We conclude that the
very limited mouse proteomics data available support the idea of similar protein levels from
the X chromosome and autosomes.
The issue described above in the analysis of the mammalian proteomics data also applies to
the prior analysis of the C. elegans proteomics data11. Furthermore, the C. elegans
proteomics data were obtained from mixed-stage animals, meaning that a large proportion of
the assayed cells were germ cells and subject to the same effect described above in the
RNA-seq analysis. Therefore, analysis of these samples is not appropriate for testing X-
linked gene upregulation.
RNA-seq data confirm dosage compensation in Drosophila
As in mammals and C. elegans, there is biased gene content on the Drosophila X
chromosome, such that there are fewer genes with male-biased expression on that
chromosome38. Although to a lesser extent than in C. elegans, the Drosophila X
chromosome is also inactivated in the late male germline14. Both of these effects reduce
overall expression measured from the X chromosome. In a previous microarray study, we
used sex reversal, which concomitantly results in the accumulation of mitotic germline cells,
to examine X-linked expression in isolation from the effects of sex-biased gene distribution
and X inactivation. We found that both somatic and germline cells have dosage
compensation8.
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We reanalyzed RNA-seq data from wild-type testes, which are expected to show decreased
X-linked expression, and from the testes of bam mutants, which contain tumors of early
mitotic male germ cells39. This analysis allowed us to remove the effects of X inactivation
and most sex-biased expression. As expected, in wild-type testis, we found that expression
of X-linked genes was significantly lower than that of autosomal genes (X:A median
expression ratios 0.64–0.71; P < 4.4 ×10−6, by Kolmogorov-Smirnov test; Fig. 5). However,
in testes from bam mutants, expression from the X chromosome was much more similar to
that from autosomes (X:A median expression ratios 0.87–0.92; P > 0.01 for 3 of 4
autosomes, by Kolmogorov-Smirnov test; Fig. 5). These results indicate that there is X
chromosome dosage compensation in early mitotic cells in the Drosophila germline.
DISCUSSION
Our reanalysis of RNA-seq data and data from new experiments are consistent with
balanced expression from the X chromosome and autosomes in mammals, C. elegans and
Drosophila. When considering expressed genes, there is strong evidence of X-linked gene
upregulation in somatic tissues in both mammals and C. elegans. This finding is similar to
what has been observed in somatic tissues of Drosophila4,5. We also confirm that there is
balanced expression of the genome, even in the Drosophila germline that lacks the canonical
compensatory MSL complex8. Furthermore, in female mouse ES cells with two active X
chromosomes, we observe a greater occupancy by RNA polymerase II of expressed X-
linked genes relative to autosomal genes, consistent with increased X-linked gene
expression in mammals27.
We arrive at a different conclusion from Xiong et al.11 for the following reasons. First, the X
chromosomes of many species have a remarkably unusual gene content, and genes with no
or very low expression in somatic tissues are especially abundant on the X chromosome, as
a result of the accumulation of genes with tissue-restricted expression on the sex
chromosomes (for example, testis, ovary or brain)12,16–18,26,40,41. The sex chromosomes are
uniquely enriched in genes involved in sexual reproduction because of evolutionary
selection mechanisms that favor location on the X or Y chromosomes12. Our reanalysis of
RNA-seq data of the distribution of gene expression in human and mouse tissues and cell
lines confirm that the X chromosome is enriched in genes with low expression in somatic
tissues but high expression in reproduction-related organs, especially the testis. We propose
that any dosage-compensation mechanism to equalize the output between the X
chromosome and autosomes is expected to target only genes that are appreciably expressed,
as there would be no need for such a mechanism to work on genes that are silent or strongly
repressed under the cellular conditions assayed. This theory has been confirmed in
Drosophila, in which the MSL complex mainly assembles at expressed genes to enhance
transcription elongation and thus increase expression from the male X chromosome42–46.
Similarly, in C. elegans, the condensin-like dosage-compensation complex binds to the
promoters of expressed genes on the X chromosomes in XX hermaphrodites47. As shown
here, inclusion of X-linked genes with very low or no expression in analyses of expression
data11 causes a shift to low median X:A expression ratio values. Second, in the C. elegans
germline, the X chromosome is largely silenced13. The declining X:A expression ratio
during development11 is therefore a reflection of the decreasing ratio of somatic to germ
cells as the germline develops in the third and fourth larval stages and does not relate to
dosage compensation. We demonstrate this by showing that the distribution of X-linked and
autosomal gene expression is very similar in near-adult XX animals lacking a germline.
X chromosome–wide silencing not only occurs in germ cells of C. elegans13 but also takes
place in male germ cells of mammals16 and Drosophila14. This complex regulation affects
X-linked expression in certain tissues or cell types. In addition, not all X-linked genes are
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dosage compensated: some genes escape upregulation in Drosophila8, and some genes
escape X inactivation in mammals48. These exceptional genes cause sex-specific differences
in gene expression, which can vary between tissues, adding another layer of complexity to
the regulation of X-linked genes49.
In conclusion, when taking into account genes implicated in sexual reproduction and unique
regulatory features of the X chromosome in particular cell types such as germ cells, Ohno’s
hypothesis that X-linked genes are overexpressed per active allele relative to autosomal
genes to regain dosage balance is supported by RNA-seq analyses and by RNA-independent
results in mammals, C. elegans and Drosophila.
URLs
MORGEN, http://www.mouseatlas.org/data/mouse/; R, http://www.r-project.org/.
ONLINE METHODS
ChIP-chip analysis of PGK12.1 ES cells
The female mouse ES cell line PGK12.1 (a gift from N. Brockdorff)50 was maintained in
standard ES medium with 1,000 U/ml leukemia inhibitory factor (LIF) (Millipore) on mouse
embryonic fibroblast (MEF) feeders. We verified that two active X chromosomes were
present by karyotyping and RNA-FISH for Xist (inactive X-specific transcripts), which
showed the absence of a Xist cloud. ChIP was performed using 5 μg of rabbit polyclonal
antibody to RNA polymerase II phosphorylated at Ser5 (PolII-S5p, Abcam) on fixed
chromatin prepared from cell pellets as described51. A 10% aliquot of chromatin was saved
as the input fraction. Immunoprecipitated chromatin and input fractions were treated with
0.2 M NaCl at 65 °C overnight to remove cross-links before DNA purification using the
QIAquick PCR purification kit (Qiagen). An aliquot was subjected to PCR for the gene
encoding the housekeeping factor β-actin to confirm the specificity of immunoprecipitation
compared to a control without antibody. ChIP DNA and input DNA were amplified using
the GenomePlex Complete Whole Genome Amplification Kit (Sigma) before labeling with
Cy5 and Cy3, respectively. Array hybridizations were performed at the Genomics Resource
Center (Fred Hutchinson Cancer Research Center, Seattle, Washington, USA) using
NimbleGen mouse 2.1 M mouse promoter arrays. GFF ratios (log2 ChIP: input ratio) and
peak files were generated using Nimblescan software. Average enrichment profiles at the 5′
ends of genes were calculated by end analysis52. A total of 16,141 autosomal genes and 647
X-linked genes were separately rank-ordered based on their expression levels by RNA-seq
analysis and divided into nine bins (bin 1 containing all genes with 0 FPKM). Two
independent biological replicates showed a high correlation (Supplementary Fig. 5).
RNA-seq data and analyses in mammals
To generate expression data for PGK12.1 ES cells by RNA-seq, purified mRNA was
fragmented into ~200 bases and reverse-transcribed with random hexamers into cDNA to
prepare a library for Illumina sequencing, by using the RNA-Seq Sample Prep kit (Illumina)
as described51. Two technical replicates of the same library were prepared for sequencing.
Sequences (total 200 million (M) 36-bp single-end reads) were aligned to the mouse
reference genome (mm9) using TopHat53 with default parameters, except that the “min-
isoform-fraction” flag was set to zero, “–no-novel-juncs” was specified to constrain the
search to annotated exon-exon boundaries and the RefSeq mouse gene annotation (mm9)
was used. Alignment resulted in 90 M mapped reads. FPKM values were obtained using
Cufflinks with default parameters and “min-isoform-fraction” set to zero54.
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Analysis of published RNA-seq data sets was based on data deposited in public databases
(Supplementary Table 1). Hi-seq data were obtained from Illumina for 16 human tissues.
The 50-bp paired-end reads had originally been analyzed as single-end reads using ELAND
and CASAVA1.6 (ref. 55) to generate reads per kilobase of exon per million mapped reads
(RPKM) values. Because the reads were analyzed as single-end reads, RPKM units are
equivalent to FPKM units. A subset of the human tissues was also reanalyzed by TopHat
and Cufflinks, which yielded similar expression profiles. In addition, removal of the
pseudoautosomal genes did not alter the expression profiles. Data for the four ENCODE
diploid cell lines was analyzed using Cufflinks with Gencode Annotation, version 3c. FPKM
values computed by Cufflinks were averaged from two biological replicates, each sequenced
to ~200 M paired-end 76-bp reads. Data for the 41 lymphoblastoid cell lines had been
previously processed to generate RPKM (FPKM) values based on single-end reads20. The
same RNA-seq data for mouse brain, liver 1 and muscle that were analyzed by Xiong et al.11
were reanalyzed using TopHat and Cufflinks as described above for PGK12.1 ES cells. Data
for the mouse liver 2 sample from MORGEN (http://www.mouseatlas.org/data/mouse/) and
for mouse E15 whole brain, preoptic area (POA) and prefrontal cortex (PFC)56 were also
reanalyzed as described above for PGK12.1 ES cells. For simplicity, all data are presented
as FPKM values. Fisher’s exact tests, one-way ANOVA tests, Kolmogorov-Smirnov tests
(two-sided) and 95% bootstrap confidence intervals were calculated in R.
C. elegans RNA-seq
The data sets and methods used for obtaining and analyzing the RNA-seq data have been
described57,58. Expression values used in those calculations are depth of coverage per
million reads (dcpm)57.
D. melanogaster RNA-seq
Raw RNA-seq data from the testes of wild-type and bam mutant organisms39 were obtained
from GEO (GSE16960). These data consist of 30-bp single-end reads, with multiple lanes
pooled together per sample. Read-mapping was performed using Tophat53 against a D.
melanogaster reference (UCSC Dm3, FlyBase release 5 assembly, excluding “chrUextra”),
turning off minimum isoform fraction filtering and setting the minimum intron size to 42 bp
(the size of the smallest annotated intron). Unique mapping was performed using Tophat
version v.1.1.4 (ref. 53) with Bowtie v.0.12.7 (ref. 59). Gene-level abundance measures
were calculated using Cufflinks53, by turning off minimum isoform fraction filtering and
supplying an annotation reference to quantify against, with all other options set at default.
The alignment reference used was from ENSEMBL release 60 (November 2010), file name
Drosophila_melanogaster.BDGP5.25.60.gtf, accessed from ftp://ftp.ensembl.org/pub/
current_gtf/. The Cufflinks version used was v.0.9.3, with SAM tools v.0.1.9 (ref. 60).
Gene-level results are reported in units of FPKM. All downstream computation, including
Mann-Whitney tests, was performed in R.
C. elegans RNA microarray
We used XO L3 animals with a genotype of her-1(e1520) sdc-3(y126) V; xol-1(y9) X that
were transformed into a hermaphrodite for ease of growth and culture61. RNA was purified
by TRIzol (Invitrogen) extraction and Qiagen RNeasy kit. Total RNA was labeled and
hybridized to single-color expression arrays at Roche NimbleGen. The normalization and
data processing were performed using NimbleScan software, which normalizes intensity
using Robust Multichip Average (RMA) and combines data from three probes per gene into
one value per gene (call). The RMA calls were log2 transformed and used for analysis. The
raw and processed data are available from the GEO database (GSE20136).
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Distributions of gene expression are similar between the X chromosome and autosomes in
human, except for reproduction-related X-linked genes not expressed in somatic tissues. (a)
Expression distributions are similar for X-linked (red) and autosomal genes (blue) in human
brain based on RNA-seq data (P = 0.71, by Kolmogorov-Smirnov test). Left, frequency of
genes with 0 FPKM; center, histograms of X-linked and autosomal expression distributions;
right, cumulative frequencies for genes with >0 FPKM. A theoretical curve (dotted red line)
generated by doubling X-linked expression does not result in equal X-linked and autosomal
distributions (P = 1 × 10−12, by Kolmogorov-Smirnov test). (b) Box plots of expression of
genes with >0 FPKM are similar from each human chromosome in brain. (c) Left, the
frequency of genes with 0 FPKM is significantly higher on the X chromosome than each
autosome except for chr. 21 in 41 lymphoblastoid cell lines (P < 0.05, by Fisher’s exact
test). Right, histograms of expression distribution for genes with >0 FPKM on each human
chromosome. (d) X:A median expression ratios increase depending on FPKM cutoffs (>0,
≥0.1, ≥0.5, ≥1 and ≥2). Ratios calculated for individual lymphoblastoid cell lines (17 female,
orange and 24 male, green) reveal variability between lines but no differences between
males and females (P > 0.05, by Student’s t-test). (e) X:A median expression ratios
calculated after separately rank-ordering X-linked and autosomal genes with >0 FPKM by
dividing them into 16 bins based on expression. Bins 1–5 contain genes with <1 FPKM
(shadowed). (f) Pairwise comparison of the distribution of gene expression in the testis
versus liver. Histograms of expression distribution for the subsets of X-linked (X) and
autosomal (A) genes expressed in testis (>0 FPKM) but not expressed (0 FPKM) in liver.
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Distributions of gene expression are similar between the X chromosome and autosomes in
mouse tissues. (a) Expression distributions are similar for X-linked (red) and autosomal
genes (blue) in mouse brain (embryonic day 15 (E15) brain) based on RNA-seq data (P =
0.04, by Kolmogorov-Smirnov test). Left, frequency of genes with 0 FPKM; center,
histograms of X-linked and autosomal expression distributions; right, cumulative
frequencies for genes with >0 FPKM. A theoretical curve (dotted red line) generated by
doubling X-linked expression does not result in equal X-linked and autosomal distributions
(P = 1 × 10−13 for E15 brain, by Kolmogorov-Smirnov test). (b) Box plots of expression of
genes with >0 FPKM are similar from each mouse chromosome in E15 brain (P > 0.05 for
expression comparison of the X chromosome versus 14 of 19 autosomes, one-way ANOVA
test). (c) Median X:A expression ratios increase depending on FPKM cutoffs (>0, ≥0.1,
≥0.5, ≥1 and ≥2). Reanalysis of RNA-seq data for mouse brain, liver and muscle. Error bars
show 95% bootstrap confidence intervals.
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Expressed X-linked genes are enriched in RNA PolII-S5p. (a) Average PolII-S5p occupancy
at the 5′ end of 647 X-linked genes (red) is higher in a 1-kb window downstream of the
transcription start site (TSS) compared to 16,141 autosomal genes (blue) in undifferentiated
female ES cells. Average occupancy (log2 ChIP: input ratio) is plotted using a 500-bp
sliding window (100-bp interval) 3 kb up- and downstream of the TSS. (b) Snapshot of
PolII-S5p occupancy in a 2-kb window downstream of the TSS relative to gene expression.
Occupancy is higher on X-linked genes (red) compared to autosomal genes (blue) for
expressed genes (bins 6–9) but not for weakly- or non-expressed genes (bins 1–5). X-linked
and autosomal genes sorted in nine bins based on expression as determined by RNA-seq.
Bin 1 contains 124 X-linked and 2,905 autosomal genes with 0 FPKM; bins 2–9 each
contain 63 X-linked and 1,596 autosomal genes. X:A median expression ratios are shown in
black for bins 2–9. Same ChIP-chip analysis as in a. Error bars show 95% bootstrap
confidence intervals. (c) Gene expression is correlated to PolII-S5p occupancy at the 5′ end
of genes. Scatter plots of average PolII-S5p occupancy in a 1-kb region downstream of the
TSS against X-linked (red) and autosomal (blue) gene expression in log2 FPKM. Same
ChIP-chip analysis as in a.
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X:A expression ratios in adult C. elegans result from the presence of germ cells in which the
X chromosomes are silenced. We rank-ordered X-linked genes according to their expression
values and divided them into 55 bins of 50 genes each. Bin 1 contained the lowest-expressed
genes, and bin 55 the highest. We likewise ranked the autosomal genes and divided them
into 55 bins. The X:A ratio of expression levels were calculated for each bin. Genes with
zero reads were included in the binning. Bins 22–48, which represent the middle of the
distribution of expression values, are plotted. This ordering removes the effect of very
highly or very weakly expressed genes (for example, in early embryo, bins 1–21 account for
0.3% of X-linked expression and 0.06% of autosomal expression). Weakly expressed genes
(for example, bins 22–31) may have higher X:A expression ratios if dosage-compensation
mechanisms work most efficiently on appreciably expressed genes.
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X chromosome dosage compensation in early mitotic cells in the Drosophila germline.
Distributions of gene-level expression values in log2 FPKM are shown by chromosome arm
(≥1 FPKM). (a–d) Red dashed lines indicate the median value for genes on the X
chromosome for ovary (a) and testis (b) from wild-type Drosophila and for ovary (c) and
testis (d) from bam mutant Drosophila.
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